HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BIBW 2992

a radiation sensitizing agent and an ErbB2 tyrosine kinase inhibitor
Also Known As:
BIBW-2992; BIBW2992
Networked: 27 relevant articles (3 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Solca, Flavio: 3 articles (06/2014 - 05/2007)
2. de Bono, Johann S: 2 articles (02/2014 - 09/2010)
3. Wheatley, Duncan: 2 articles (02/2014 - 06/2012)
4. Temple, Graham: 2 articles (02/2014 - 09/2010)
5. Hickish, Tamas: 2 articles (02/2014 - 06/2012)
6. Zips, Daniel: 2 articles (01/2014 - 05/2007)
7. Baumann, Michael: 2 articles (01/2014 - 05/2007)
8. Krause, Mechthild: 2 articles (01/2014 - 05/2007)
9. Eicheler, Wolfgang: 2 articles (01/2014 - 05/2007)
10. Wong, Kwok-Kin: 2 articles (11/2012 - 01/2009)

Related Diseases

1. Lung Neoplasms (Lung Cancer)
2. Neoplasms (Cancer)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Prostatic Neoplasms (Prostate Cancer)
5. Osteosarcoma (Osteogenic Sarcoma)

Related Drugs and Biologics

1. erlotinib (CP 358,774)
2. Protein-Tyrosine Kinases (Tyrosine Kinase)
3. ARQ 197
4. gefitinib (Iressa)
5. trastuzumab (Herceptin)
6. Epidermal Growth Factor Receptor (EGF Receptor)
7. Sirolimus (Rapamycin)
8. Phosphotransferases (Kinase)
9. Paclitaxel (Taxol)
10. vorinostat (suberoylanilide hydroxamic acid)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Stents
4. Radiotherapy
5. Castration